Ahammune BioSciences

Vitiligo is a skin condition in which white patches appear on the skin due to the death of color-producing cells. This debilitating disease is a cause of immense psychological torment and is considered as a social stigma. At Ahammune, their endeavour is to resolve and treat the long-standing skin depigmentation disorder Vitiligo that has
affected the life of millions of people. They are currently developing new chemical/molecular entities (NCE/NME’s) for stalling the spread of depigmentation in Vitiligo.

Embryyo

2

Embryyo is a medical devices and healthcare solutions based company. They are working for devoloping innovative medical devices like Pill-box for TB drug adherance monitoring, non-invasive billirubin meter for neonatal jaundice, cervical cancer screening, etc for addressing women and maternal health, child health, public health. The company is Bill & melinda gates foundation grantee and winner of Grand challenges in TB control and Global health. Embryyo has also received SPARSH grant by DBT-BIRAC, GoI. They are the winner of USAID and “Innovator for Digital India Challenge”. Embryyo is founded by Nishant kumar who is an alumnus of IIT-Bombay and Ex-Philips Healthcare

Website: http://www.embryyo.com/